Harmony Biosciences Hldg Inc (HRMY)
EBITDA Growth
72.66%
Quarterly · Period ending:
HRMY EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported72.66%period ending
Latest reported72.66%period ending
HRMY Quarterly EBITDA YoY % (87.75% → 72.66%)
Year-over-year change
High-resolution chart · PNG
HRMY ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 72.6633% | |
| -27.0106% | |
| -22.0014% | |
| 1.3409% | |
| 84.2924% | |
| 7.2657% | |
| 8.3078% | |
| 11.6028% | |
| -42.9732% | |
| 25.9586% | |
| 13.9338% | |
| 260.4329% | |
| 43.7712% | |
| 51.3602% | |
| 640.3113% | |
| 4,380.285% | |
| 39.8217% | |
| 70.6596% | |
| -40.1944% | |
| -103.4097% | |
| 201.1382% | |
| 348.408% | |
| 138.2418% | |
| 142.9446% | |
| 148.6573% | |
| 87.747% |